Novo Nordisk Foundation
Infectious Diseases – Catalyst Grants Call 2026
2026 call; specific deadline not stated in this segment
Last verified:
Details
| Funder | Novo Nordisk Foundation |
| Budget | Up to DKK 4M (single Nordic applicant) or up to DKK 7M (Nordic main + international co-applicant) |
| Duration | Up to 3 years |
| Consortium | Optional — Nordic main applicant required; co-applicant (if any) must be in a different country |
| Application | Single stage — submitted via NORMA online system |
| Frequency | Annual |
| Eligible countries | DK |
Eligibility & scope
Main applicant must be based in the Nordics. Co-applicant (optional) must be in a different country. Scope: novel AMR tools (WHO Bacterial Priority Pathogen List) or pandemic influenza research; must be use-inspired. Out of scope: clinical trials, surveillance, phage therapy, microbiome, for-profit product development. Total call budget DKK 60M.
More from Novo Nordisk Foundation
Interdisciplinary Synergy Programme 2026
Deadline: 20 May 2026Up to DKK 19.4 million per grantNovo Nordisk Foundation Interdisciplinary Synergy Programme 2026
Deadline: 20 May 2026Up to DKK 19.4M (~€2.6M)Steno Collaborative Grants
Deadline: 2 Jun 2026DKK 1M–DKK 10M per grant (total pool up to DKK 30M)Non-Diabetic Endocrinology Collaborative Grants 2026
Deadline: 3 Jun 2026DKK 5M–10M per grant (total pool up to DKK 53M)Project grants in Endocrinology and Metabolism – Nordic Region
Deadline: 4 Jun 2026Up to DKK 4.5 million per grant
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free